News

European Patient Innovation Summit: Using digital technology to improve patient care

EMSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External…

EURORDIS: Patient survey on adverse drug reactions

EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURODIS) aimed at reporting side-effects and receiving safety information on medicines through an app for mobile phones and tablets.

ECTRIMS 2016: Upcoming MS treatments

The ECTRIMS 2016 Congress offered encouraging treatment news for patients with relapsing (RMS) and secondary progressive (SPMS) forms of multiple sclerosis (MS).

ECTRIMS 2016: Upcoming MS treatments

The ECTRIMS 2016 Congress offered encouraging news on MS treatments for patients with relapsing (RMS) and secondary progressive (SPMS) multiple…

Sailing Sclerosis: Oceans of Hope boat tours continue in 2017

After completing the world circumnavigation with crews of people living with multiple sclerosis (MS), the Oceans of Hope flotilla now takes…

EMSP at ECTRIMS 2016: Delivering for MS communities

EMSP’s team was present between 13 and 17 September at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2016), held for the first time in London, United Kingdom.

We were among 9,000 participants from almost 100 countries worldwide. And we took full advantage of this record attendance to promote our key deliverables for the MS communities in Europe and plan for the road ahead together with our partners and supporters.